SUBLEASE TERMINATION AND RELEASE AGREEMENTSublease Termination and Release Agreement • May 15th, 2023 • Magenta Therapeutics, Inc. • Pharmaceutical preparations
This Sublease Termination and Release Agreement (“Agreement”) is entered into as of March 31, 2023, by and between NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC., a Delaware corporation, having an address at 100 Technology Square, Cambridge, Massachusetts 02139 (“Novartis”), and MAGENTA THERAPEUTICS, INC., a Delaware corporation, having an address at 100 Technology Square, Cambridge, Massachusetts 02139 (“Subtenant”).
